Adherence to SARS-CoV-2 Vaccination Recommendations among Patients with Substance Use Disorders: A Cross-Sectional Study in Rome, Italy.

COVID-19 health disparities substance use disorders vaccination coverage vaccine hesitancy vaccines

Journal

Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355

Informations de publication

Date de publication:
30 Aug 2023
Historique:
received: 30 07 2023
revised: 25 08 2023
accepted: 29 08 2023
medline: 28 9 2023
pubmed: 28 9 2023
entrez: 28 9 2023
Statut: epublish

Résumé

Adherence to vaccination recommendations is a challenge for national immunization programs. We quantified adherence to COVID-19 vaccination recommendations in people with substance use disorders (SUDs) attending an outpatient addiction center in Rome, Italy; we investigated the determinants of adherence, and also analyzed patient risk perception and compliance with preventive measures. A multivariable logistic regression model identified predictors of adherence to vaccination recommendations, with statistical validity tested by estimating adjusted odds ratios (aORs) and 95% confidence intervals (CIs). From December 2021 to January 2022, 200 SUD patients completed a questionnaire, 80% of whom reported being vaccinated against SARS-CoV-2 (minimum one dose). Negative predictors of vaccine uptake included being non-Italian (aOR: 0.36, 95% CI: 0.13-0.97), having coexisting comorbidities (aOR: 0.35, 95% CI: 0.13-0.95), and previous use of heroin (aOR: 0.24, 95% CI: 0.08-0.71). No difference was found for cocaine use, demographic characteristics, previous COVID-19 infection, methadone therapy, or compliance with preventive measures. Major reasons for non-adherence to vaccination recommendations were fear of side effects, insufficient recognition of the importance of vaccination, bureaucratic issues, and lack of trust in the authorities. Given their vulnerability, additional efforts are needed to facilitate access to vaccination for people with SUDs, and to limit disinformation around vaccines..

Identifiants

pubmed: 37766111
pii: vaccines11091434
doi: 10.3390/vaccines11091434
pmc: PMC10538200
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Turk J Med Sci. 2020 Apr 15;50(SI-1):571-577
pubmed: 32293835
Nat Hum Behav. 2021 Mar;5(3):337-348
pubmed: 33547453
Vaccine. 2021 Oct 8;39(42):6256-6261
pubmed: 34544601
Int J Surg. 2020 Jun;78:185-193
pubmed: 32305533
J Med Internet Res. 2022 Apr 26;24(4):e36830
pubmed: 35380546
JAMA Netw Open. 2021 Sep 1;4(9):e2127582
pubmed: 34591103
Bull World Health Organ. 2022 Sep 1;100(9):544-561
pubmed: 36062247
Hum Vaccin Immunother. 2020 Nov 1;16(11):2618-2627
pubmed: 32209017
Addiction. 2018 Jan;113(1):80-90
pubmed: 28710874
Lancet Diabetes Endocrinol. 2022 Aug;10(8):571-580
pubmed: 35780805
Psychiatry Res. 2020 Jul;289:113096
pubmed: 32405115
Vaccines (Basel). 2022 Feb 25;10(3):
pubmed: 35334995
Front Public Health. 2022 Sep 06;10:931306
pubmed: 36148330
PLoS One. 2021 Dec 1;16(12):e0259696
pubmed: 34851970
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
Nat Commun. 2021 Dec 14;12(1):7272
pubmed: 34907206
Lancet Infect Dis. 2022 Jun;22(6):745-747
pubmed: 35366961
Lancet. 2022 Apr 16;399(10334):1513-1536
pubmed: 35279232
Soc Sci Med. 2021 Mar;272:113688
pubmed: 33485215
Lancet. 2022 Mar 5;399(10328):924-944
pubmed: 35202601
Vaccines (Basel). 2022 Sep 07;10(9):
pubmed: 36146566
Drug Alcohol Depend. 2021 Sep 1;226:108882
pubmed: 34216866
Drug Alcohol Rev. 2022 Sep;41(6):1311-1318
pubmed: 35668697
Vaccines (Basel). 2021 Nov 07;9(11):
pubmed: 34835223
Drug Alcohol Depend. 2021 Mar 1;220:108519
pubmed: 33461150
Mayo Clin Proc. 2020 Dec;95(12):2709-2718
pubmed: 33276843
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Sci Rep. 2022 Apr 26;12(1):5966
pubmed: 35474313
Mol Psychiatry. 2021 Jan;26(1):30-39
pubmed: 32929211
Hum Vaccin Immunother. 2021 Oct 3;17(10):3348-3354
pubmed: 34096836
Psychiatr Clin North Am. 2022 Mar;45(1):95-107
pubmed: 35219445
Harm Reduct J. 2022 Jun 3;19(1):59
pubmed: 35655217
Vaccines (Basel). 2023 Mar 23;11(4):
pubmed: 37112633
BMC Infect Dis. 2021 Apr 12;21(1):338
pubmed: 33845781

Auteurs

Francesco Mondera (F)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Vincenzo Cammalleri (V)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Francesca Maria Forestiero (FM)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Federica Turatto (F)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Giovanni F M Direnzo (GFM)

Villa Maraini Foundation, 00151 Rome, Italy.

Anna Napoli (A)

Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.

Francesca Pirelli (F)

Department of Physiology and Pharmacology, Sapienza University of Rome, 00185 Rome, Italy.

Nirinalisera Razafimpanana (N)

Department of Physiology and Pharmacology, Sapienza University of Rome, 00185 Rome, Italy.

Ettore Rossi (E)

Villa Maraini Foundation, 00151 Rome, Italy.

Valentina Baccolini (V)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Lilia Cinti (L)

Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.

Carolina Marzuillo (C)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Massimo Barra (M)

Villa Maraini Foundation, 00151 Rome, Italy.

Guido Antonelli (G)

Department of Molecular Medicine, Sapienza University of Rome, 00185 Rome, Italy.

Aldo Badiani (A)

Villa Maraini Foundation, 00151 Rome, Italy.
Department of Physiology and Pharmacology, Sapienza University of Rome, 00185 Rome, Italy.

Paolo Villari (P)

Department of Public Health and Infectious Diseases, Sapienza University of Rome, 00185 Rome, Italy.

Classifications MeSH